Biggest News Aggregation in the World
📰 Hunterc Smith News

Page 2 - Hunterc Smith News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Hunterc Smith. Real-time updates on events, politics, business and more.

Rhythm Pharmaceuticals (NASDAQ:RYTM) Shares Gap Down to $47.20

Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Get Free Report)’s stock price gapped down prior to trading on Monday . The stock had previously closed at $47.20, but opened at $45.74. Rhythm Pharmaceuticals shares last traded at $46.02, with a volume of 87,390 shares trading hands. Wall Street Analysts Forecast Growth A number of research firms have […]
United States Hunterc Smith Jennifer Kayden Lee Rhythm Pharmaceuticals Trading Rhythm Pharmaceuticals Inc Goldman Sachs Group

Rhythm Pharmaceuticals (NASDAQ:RYTM) PT Raised to $42.00

Rhythm Pharmaceuticals (NASDAQ:RYTM – Free Report) had its price target increased by The Goldman Sachs Group from $38.00 to $42.00 in a report published on Thursday morning, Benzinga reports. The Goldman Sachs Group currently has a buy rating on the stock. Several other equities analysts have also recently weighed in on the stock. Wells Fargo […]
Hunterc Smith Jennifer Kayden Lee Blackrock Inc Hermes Inc Goldman Sachs Group Rhythm Pharmaceuticals
Source: wkrb13.com

Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Receives $37.71 Consensus Price Target from Brokerages

Shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the seven ratings firms that are presently covering the stock, Marketbeat Ratings reports. One equities research analyst has rated the stock with a hold rating and six have assigned a buy rating to the company. […]
Jennifer Kayden Lee Hunterc Smith Needham Company Rhythm Pharmaceuticals Stock Down Ameritas Investment Partners Inc Securities Exchange Commission

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Receives $37.71 Average PT from Analysts

Shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Get Free Report) have received an average rating of “Moderate Buy” from the seven analysts that are presently covering the firm, Marketbeat reports. One research analyst has rated the stock with a hold rating and six have issued a buy rating on the company. The average 12-month price […]
United States Hunterc Smith Life Insurance Co Morgan Stanley Chicago Partners Investment Group China Universal Asset Management Co
Source: wkrb13.com

Insider Selling: Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) CFO Sells 7,026 Shares of Stock

Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Get Free Report) CFO Hunter C. Smith sold 7,026 shares of Rhythm Pharmaceuticals stock in a transaction dated Tuesday, December 5th. The shares were sold at an average price of $35.06, for a total transaction of $246,331.56. Following the sale, the chief financial officer now directly owns 61,406 shares in […]
United States Hunterc Smith Wells Fargo Company News Ratings For Rhythm Pharmaceuticals Daily Allspring Global Investments Holdings Rhythm Pharmaceuticals Stock Performance

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science